Since human PB DCs can be divided, on the basis of expression of the β-integrin CD11c (Robinson et al, 1999), into two subpopulations that differ in the origin, expression of phenotypic markers, route of activation and immunological activity, we evaluated their distribution in our patients.
Since we do not know whether GPRC5A/D is expressed in parts of the gill of endodermal origin, we cannot draw conclusions about putative similarities to the expression of GPRC5A in the mammalian lung, also being of endodermal origin, although expression of the receptors in endodermal structures might be evolutionarily conserved.
At chromosome 11p15.5, the imprinting centre 1 (Icontrolsrols the parent of origin-specific expression of the IGF2 and H19 genes.
Allele-specific binding of CTCF to the ICR regulates parent-of-origin-specific expression of the IGF2 gene and correlates with differential cytosine methylation and the presence of H3K9me3 [ 9- 11].
Taking cues from chromatin signatures at imprinted gene loci such as the insulin-like growth factor 2 gene 2 (IGF2), we evaluated the contribution of CTCF, a zinc finger protein required for parent-of-origin-specific expression of the IGF2 gene, as well as a role for allele-specific association with DNA methylation, histone modification and RNA polymerase II.
Such variation suggests that the cellular origin of the expression of the cell cycle 5 gene set may change across development.
Here we present studies that address the origin, distribution and expression of the D2 GALT allele.
These data provide the first detailed descriptions of the stromal vs epithelial origin of the expression of the proteases and inhibitors, and indicate that several proteolysis-associated genes may be useful prognostic indicators in prostate cancer.
So far, the most described oxidases are from eukaryotic origin, and heterologous expression of the recombinant protein in Escherichia coli for large scale enzyme production can be problematic.
We now describe this is in the legend of Figure 2. In the subsection "Transcriptome-Wide Profile of Parent-of-Origin Expression in the Mouse Cerebellum", you state: "our approach has a true positive rate of 93%" – based on what?
